Aristotle University Of Thessaloniki (AUTH)
Η μελέτη της έκφρασης των υποδοχέων της φυσικής ανοσίας στη λοίμωξη και στη σήψη
Abstract
dc:descriptionSepsis is a complex syndrome characterized by the presence of infection and generalized, dysregulated immune response. Sepsis diagnosis is based on the identification of Systemic Inflammatory Response Syndrome (SIRS) and a severe, uncontrolled infection. Modern medical research is investigating for biomarkers to elucidate the presence or absence of sepsis and to predict the outcome of the disease. Triggering receptor expressed on myelocytes-1 (TREM-1) is expressed on the surface of neutrophils, CD14+ monocytes and macrophages. It belongs to the immunoglobulin superfamily and is mainly induced by Toll-like receptors (TLR4) activation. Activation of TREM-1 results in increased production of proinflammatory cytokines, chemokines, and co-stimulatory molecules. A total of 70 individuals were studied in 3 groups. Thirty-seven patients (groupA) were suffering from septic syndrome, (according to the definitions Center of Disease Control (CDC)), of which 27 had sepsis without organ damage and 10 patients had severe sepsis/septic shock. In group B were included 16 patients with systemic autoimmune rheumatic diseases (8 patients with Rheumatoid Arthritis (RA) (group B1) and 8 patients with Systemic Lupus Erithymatosus (SLE) (group B2) fulfilling at least 2/4 SIRS criteria. In group C were included 17 healthy individuals.The purpose of this study was to evaluate the membrane TREM-1 in co -expression with membrane PRR receptor TLR4 on CD14+ monocytes and the soluble receptor TREM-1 in the diagnosis of sepsis. Diagnostic accuracy of sTREM-1 was compared to the established marker procalcitonin (PCT). In all study groups were obtained:a.the percentage expression of TLR4+/TREM-1+ in CD14+ monocytes and the mean fluorescence intensity compared to the non-specific immunofluorescence (IgG/CD14) by flow cytometry (FACS) b.the levels of sTREM-1 in serum with ELISA c.levels of PCT in serum with ELFAThe results showed that:•Both forms m/sTREM-1 are increased in patients with sepsis compared to patients with autoimmune systemic diseases exhibiting SIRS (RA-SLE•Both forms m/sTREM-1 are increased in patients with SIRS and autoimmune systemic diseases (RA-SLE) compared to healthy individuals. •The prognostic value of TREM-1 in determining the severity of sepsis is significant only in septic patients suffering from septic shock but not in less severe disease •m/sTREM-1 levels were relatively lower in urosepsis than in other infections, probably due to the more compartmentalized nature of pyelonephritis. The levels of m/s TREM-1 were not associated with the responsible isolated pathogen. •Although elevated in patients with RA, m/sTREM-1 were not related to DAS index. In patients with SLE, sTREM-1 levels were associated with the SLEDAI but not the mTREM-1 expression on CD14+ monocytes. In conclusion, m/sTREM-1 is a biomarker that could facilitate the diagnosis and monitoring of sepsis. Co-evaluation of m/sTREM-1 with other biomarkers such as PCT could increase the overall diagnostic accuracy, regarding septic and autoimmune SIRS.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2016
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Gkougkourelas, Ioannis
- Γκουγκουρέλας, Ιωάννης
Subjects
dc:subject × 8Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/38411